(Q77965259)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10395021%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

title

Methotrexate produces delayed emesis in dogs: a potential model of delayed emesis induced by chemotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10395021%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

Fukui H

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10395021%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Yamamoto M

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10395021%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

publication date

1 May 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10395021%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Pharmacology

9 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10395021%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

volume

372

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10395021%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10395021%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

page(s)

261-267

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10395021%20AND%20SRC:MED&resulttype=core&format=json

Neuropharmacology of emesis induced by anti-cancer therapy.

9 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900219-8

The abdominal visceral innervation and the emetic reflex: pathways, pharmacology, and plasticity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900219-8

Delata-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. A prospective, randomized evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900219-8

Ondansetron compared with high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting. A multicenter, randomized, double-blind, crossover study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900219-8

Pharmacological characterization of RS 25259-197, a novel and selective 5-HT3 receptor antagonist, in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900219-8

Increase in serotonin levels in the dog ileum and blood by cisplatin as measured by microdialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900219-8

Emetic effects of anticancer drugs and involvement of visceral afferent fibers and 5-HT3 receptors in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900219-8

The effects of orally administered Y-25130, a selective serotonin3-receptor antagonist, on chemotherapeutic agent-induced emesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900219-8

Proposal for classifying the acute emetogenicity of cancer chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900219-8

Ondansetron versus metoclopramide, both combined with dexamethasone, in the prevention of cisplatin-induced delayed emesis. The Italian Group for Antiemetic Research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900219-8

The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900219-8

Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900219-8

Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900219-8

Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900219-8

Immunologic studies of rheumatoid arthritis patients treated with methotrexate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900219-8

An interaction of ondansetron and dexamethasone antagonizing cisplatin-induced acute and delayed emesis in the ferret

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900219-8

Profiles of emetic action of cisplatin in the ferret: a potential model of acute and delayed emesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900219-8

The interaction of dexamethasone with ondansetron on drug-induced emesis in the ferret

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900219-8

Antiemetic activity of the new 5-HT3 antagonist DAU 6215 in animal models of cancer chemotherapy and radiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900219-8

Methotrexate: mechanism of action in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900219-8

Physiology of chemotherapy-induced emesis and antiemetic therapy. Predictive models for evaluation of new compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900219-8

Vagal afferent fibers and peripheral 5-HT3 receptors mediate cisplatin-induced emesis in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2899%2900219-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(99)00219-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10395021%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference